Financhill
Back

Akari Therapeutics PLC 10K Form

Sell
27

AKTX
Akari Therapeutics PLC

Last Price:
2.27
Seasonality Move:
-8%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive AKTX News And Ratings

See the #1 stock for the next 7 days that we like better than AKTX

AKTX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-4.89M
Price / Cash Flow: 0
Annual Sales: $-0.30
Price / Book: 0

Profitability

EPS (TTM): -2.15650
Net Income (TTM): $-16.12M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Akari Therapeutics PLC Earnings Forecast

Key Akari Therapeutics PLC Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 14 years have been positive in 7 years.

Akari Therapeutics PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AKTX
CUSIP: 00972G
Website: akaritx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AKTX Technical Analysis vs Fundamental Analysis

Sell
27
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy or a Sell?